ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

FluBlok

Also written as “UMN-0501”, “Seasonal Influenza Vaccine (SIV) (Flublok)” and “FluBlok®”.

Its studies are mostly in Influenza, Human · Pneumococcal Infections, led by 4 companies.

Drug pageFluBlok: every studyAll 13 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 3, since May 17, 20067 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Protein Sciencesits history only30 open or runningphase 3since May 17, 2006May 17, 2006none ahead
Shionogi20 open or runningphase 2since Sep 17, 2009Sep 17, 2009none ahead
Sanofiits history only10 open or runningphase 3since Oct 3, 2007Oct 3, 2007none ahead
Vaxcyteits history only10 open or runningphase 3since Jan 22, 2026Jan 22, 2026none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Shionogi only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Sep 17, 2009First study: phase 2 study in Influenza, HumanFirst studyNCT00980447 · 90 enrolled · Japan
  2. Sep 2, 2010Phase 2 study in Influenza, HumanNCT01195038 · 87 enrolled · Japan

TargetBeta

A vaccine: it acts on a pathogen, not a human gene.

Studies

All 2 Shionogi leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT01195038Influenza, Human · Japan2CompletedJan 201187
NCT00980447Influenza, Human · Japan2CompletedDec 200990

How it is read

Names in the registry

  • “UMN-0501”, 3 entries
  • “Seasonal Influenza Vaccine (SIV) (Flublok)”, 1 entry
  • “FluBlok®”, 1 entry
  • “Flublok”, 1 entry
  • “FluBlok Influenza Vaccination”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.